Wood, Nolan
503  results:
Search for persons X
?
1

The use of quantitative clinical pharmacology approaches to..:

Wood, Nolan D. ; Smith, Danelle ; Kinrade, Sally A....
PLOS Neglected Tropical Diseases.  18 (2024)  8 - p. e0012351 , 2024
 
?
2

Safety and Pharmacokinetics of Single Ascending Doses of KN..:

OBrien, Christopher ; Morgan, Frazer ; Wood, Nolan...
Journal of Allergy and Clinical Immunology.  153 (2024)  2 - p. AB142 , 2024
 
?
3

Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxy..:

Plock, Nele ; Facius, Axel ; Lahu, Gezim...
Clinical Pharmacokinetics.  54 (2014)  4 - p. 385-395 , 2014
 
?
4

Effects of Hepatic Dysfunction on the Single-Dose Pharmacok..:

de Mey, Christian ; Mateva, Lyudmila ; Krastev, Zahariy...
The Journal of Clinical Pharmacology.  51 (2011)  3 - p. 397-405 , 2011
 
?
5

Evaluation of drug–drug interactions with fesoterodine:

Malhotra, Bimal ; Sachse, Richard ; Wood, Nolan
European Journal of Clinical Pharmacology.  65 (2009)  6 - p. 551-560 , 2009
 
?
6

Assessment of the Effects of Renal Impairment on the Pharma..:

Malhotra, Bimal ; Gandelman, Kuan ; Sachse, Richard.
The Journal of Clinical Pharmacology.  49 (2009)  4 - p. 477-482 , 2009
 
?
 
?
8

Investigation of the Potential Relationships Between Plasma..:

Tan, Keith ; Brayshaw, Nigel ; Tomaszewski, Konrad..
The Journal of Clinical Pharmacology.  46 (2006)  2 - p. 235-243 , 2006
 
?
9

The pharmacokinetics and safety of intravenous voriconazole..:

Purkins, Lynn ; Wood, Nolan ; Greenhalgh, Katie...
British Journal of Clinical Pharmacology.  56 (2003)  s1 - p. 2-9 , 2003
 
?
10

Voriconazole, a novel wide‐spectrum triazole: oral pharmaco..:

Purkins, Lynn ; Wood, Nolan ; Greenhalgh, Katie..
British Journal of Clinical Pharmacology.  56 (2003)  s1 - p. 10-16 , 2003
 
?
11

Safety of Voriconazole and Dose Individualization:

Lutsar, Irja ; Hodges, Mike R. ; Tomaszewski, Konrad..
Clinical Infectious Diseases.  36 (2003)  8 - p. 1087-1088 , 2003
 
?
12

Histamine H2‐receptor antagonists have no clinically signif..:

Purkins, Lynn ; Wood, Nolan ; Kleinermans, Diane.
British Journal of Clinical Pharmacology.  56 (2003)  s1 - p. 51-55 , 2003
 
?
13

No clinically significant effect of erythromycin or azithro..:

Purkins, Lynn ; Wood, Nolan ; Ghahramani, Parviz...
British Journal of Clinical Pharmacology.  56 (2003)  s1 - p. 30-36 , 2003
 
?
14

Voriconazole potentiates warfarin‐induced prothrombin time ..:

Purkins, Lynn ; Wood, Nolan ; Kleinermans, Diane.
British Journal of Clinical Pharmacology.  56 (2003)  s1 - p. 24-29 , 2003
 
?
15

No clinically significant pharmacokinetic interactions betw..:

Purkins, Lynn ; Wood, Nolan ; Kleinermans, Diane.
British Journal of Clinical Pharmacology.  56 (2003)  s1 - p. 62-68 , 2003
 
1-15